Invivyd Advances VYD2311: New Choice for COVID Protection
Invivyd is developing VYD2311, a non-vaccine antibody, to prevent COVID. Two key trials (DECLARATION/LIBERTY) will test its safety and effectiveness vs. placebo and mRNA vaccines, aiming to offer a flexible new choice for protection.
Already have an account? Sign in.